 Tatva Chintan Pharma Chem Ltd consolidated Q2FY26 PAT climbs to Rs. 9.91 crores
Tatva Chintan Pharma Chem Ltd consolidated Q2FY26 PAT climbs to Rs. 9.91 crores GPT Infraprojects Ltd receives contract worth Rs. 37.8 crore
GPT Infraprojects Ltd receives contract worth Rs. 37.8 crore Dr Lal PathLabs Limited recommends 1:1 bonus issue
Dr Lal PathLabs Limited recommends 1:1 bonus issue RITES signs MoU with Shipping Corporation of India
RITES signs MoU with Shipping Corporation of India XTGlobal announces new client win for Circulus AP Automation Solution in the U.S. Construction Sector
XTGlobal announces new client win for Circulus AP Automation Solution in the U.S. Construction Sector 
              Panacea Biotec Ltd had allotted 1,63,00,000 (One Crore Sixty Three Lac Only) 0.5%, Non-Convertible Cumulative Redeemable Preference Shares ('NCCRPS') of Rs.10 (Rupees Ten) each at par aggregating to Rs. 16.30 (Rupees Sixteen Crore Thirty lac Only) on private placement basis to the promotes of the Company in pursuance of Special Resolution passed by the shareholders in their Extra-Ordinary General Meeting held on January 06, 2015 at the Registered Office of the Company.
Further, the aforesaid shares are issued in physical form and the Company does not intend to list the aforesaid shares on Stock exchange(s).
Shares of PANACEA BIOTEC LTD. was last trading in BSE at Rs.146.65 as compared to the previous close of Rs. 149.35. The total number of shares traded during the day was 9385 in over 603 trades.
The stock hit an intraday high of Rs. 151.6 and intraday low of 146. The net turnover during the day was Rs. 1391502.